IGHMBP2 and Spinal muscular atrophy with respiratory distress type 1: Thus, the reduction in IGHMBP2 protein might be part of the pathogenesis of SMARD1/CMT2S that could result from post-translational degradation (4) or inhibition of nonsense-mediated RNA decay (NMD) (18).